Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Insomnia Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Insomnia Therapy Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Non-pharmacological Therapy
    • 1.4.3 Pharmacological Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Insomnia Therapy Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Ambulatory Surgical Center
    • 1.5.4 Home Care
  • 1.6 Coronavirus Disease 2019 (Covid-19): Insomnia Therapy Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Insomnia Therapy Industry
      • 1.6.1.1 Insomnia Therapy Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Insomnia Therapy Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Insomnia Therapy Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Insomnia Therapy Market Perspective (2015-2026)
  • 2.2 Insomnia Therapy Growth Trends by Regions
    • 2.2.1 Insomnia Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Insomnia Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Insomnia Therapy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Insomnia Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Insomnia Therapy Players by Market Size
    • 3.1.1 Global Top Insomnia Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Insomnia Therapy Market Concentration Ratio
    • 3.2.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2019
  • 3.3 Insomnia Therapy Key Players Head office and Area Served
  • 3.4 Key Players Insomnia Therapy Product Solution and Service
  • 3.5 Date of Enter into Insomnia Therapy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Insomnia Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Insomnia Therapy Forecasted Market Size by Type (2021-2026)

5 Insomnia Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Insomnia Therapy Market Size by Application (2015-2020)
  • 5.2 Global Insomnia Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Insomnia Therapy Market Size (2015-2020)
  • 6.2 Insomnia Therapy Key Players in North America (2019-2020)
  • 6.3 North America Insomnia Therapy Market Size by Type (2015-2020)
  • 6.4 North America Insomnia Therapy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Insomnia Therapy Market Size (2015-2020)
  • 7.2 Insomnia Therapy Key Players in Europe (2019-2020)
  • 7.3 Europe Insomnia Therapy Market Size by Type (2015-2020)
  • 7.4 Europe Insomnia Therapy Market Size by Application (2015-2020)

8 China

  • 8.1 China Insomnia Therapy Market Size (2015-2020)
  • 8.2 Insomnia Therapy Key Players in China (2019-2020)
  • 8.3 China Insomnia Therapy Market Size by Type (2015-2020)
  • 8.4 China Insomnia Therapy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Insomnia Therapy Market Size (2015-2020)
  • 9.2 Insomnia Therapy Key Players in Japan (2019-2020)
  • 9.3 Japan Insomnia Therapy Market Size by Type (2015-2020)
  • 9.4 Japan Insomnia Therapy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Insomnia Therapy Market Size (2015-2020)
  • 10.2 Insomnia Therapy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Insomnia Therapy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Insomnia Therapy Market Size by Application (2015-2020)

11 India

  • 11.1 India Insomnia Therapy Market Size (2015-2020)
  • 11.2 Insomnia Therapy Key Players in India (2019-2020)
  • 11.3 India Insomnia Therapy Market Size by Type (2015-2020)
  • 11.4 India Insomnia Therapy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Insomnia Therapy Market Size (2015-2020)
  • 12.2 Insomnia Therapy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Insomnia Therapy Market Size by Type (2015-2020)
  • 12.4 Central & South America Insomnia Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Merck & Co.
    • 13.1.1 Merck & Co. Company Details
    • 13.1.2 Merck & Co. Business Overview and Its Total Revenue
    • 13.1.3 Merck & Co. Insomnia Therapy Introduction
    • 13.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2015-2020))
    • 13.1.5 Merck & Co. Recent Development
  • 13.2 Sanofi
    • 13.2.1 Sanofi Company Details
    • 13.2.2 Sanofi Business Overview and Its Total Revenue
    • 13.2.3 Sanofi Insomnia Therapy Introduction
    • 13.2.4 Sanofi Revenue in Insomnia Therapy Business (2015-2020)
    • 13.2.5 Sanofi Recent Development
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Details
    • 13.3.2 Pfizer Business Overview and Its Total Revenue
    • 13.3.3 Pfizer Insomnia Therapy Introduction
    • 13.3.4 Pfizer Revenue in Insomnia Therapy Business (2015-2020)
    • 13.3.5 Pfizer Recent Development
  • 13.4 Takeda Pharmaceutical Company Ltd.
    • 13.4.1 Takeda Pharmaceutical Company Ltd. Company Details
    • 13.4.2 Takeda Pharmaceutical Company Ltd. Business Overview and Its Total Revenue
    • 13.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
    • 13.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020)
    • 13.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
  • 13.5 Purdue Pharmaceuticals L.P.
    • 13.5.1 Purdue Pharmaceuticals L.P. Company Details
    • 13.5.2 Purdue Pharmaceuticals L.P. Business Overview and Its Total Revenue
    • 13.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
    • 13.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020)
    • 13.5.5 Purdue Pharmaceuticals L.P. Recent Development
  • 13.6 Eisai, Co. Ltd.
    • 13.6.1 Eisai, Co. Ltd. Company Details
    • 13.6.2 Eisai, Co. Ltd. Business Overview and Its Total Revenue
    • 13.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
    • 13.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020)
    • 13.6.5 Eisai, Co. Ltd. Recent Development
  • 13.7 Meda Consumer Healthcare
    • 13.7.1 Meda Consumer Healthcare Company Details
    • 13.7.2 Meda Consumer Healthcare Business Overview and Its Total Revenue
    • 13.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
    • 13.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020)
    • 13.7.5 Meda Consumer Healthcare Recent Development
  • 13.8 Pernix Therapeutics
    • 13.8.1 Pernix Therapeutics Company Details
    • 13.8.2 Pernix Therapeutics Business Overview and Its Total Revenue
    • 13.8.3 Pernix Therapeutics Insomnia Therapy Introduction
    • 13.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
    • 13.8.5 Pernix Therapeutics Recent Development
  • 13.9 Vanda Pharmaceuticals
    • 13.9.1 Vanda Pharmaceuticals Company Details
    • 13.9.2 Vanda Pharmaceuticals Business Overview and Its Total Revenue
    • 13.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
    • 13.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
    • 13.9.5 Vanda Pharmaceuticals Recent Development
  • 13.10 ECR Pharmaceuticals
    • 13.10.1 ECR Pharmaceuticals Company Details
    • 13.10.2 ECR Pharmaceuticals Business Overview and Its Total Revenue
    • 13.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
    • 13.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
    • 13.10.5 ECR Pharmaceuticals Recent Development
  • 13.11 Fidia Farmaceutici
    • 10.11.1 Fidia Farmaceutici Company Details
    • 10.11.2 Fidia Farmaceutici Business Overview and Its Total Revenue
    • 10.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
    • 10.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020)
    • 10.11.5 Fidia Farmaceutici Recent Development
  • 13.12 Dainippon Sumitomo
    • 10.12.1 Dainippon Sumitomo Company Details
    • 10.12.2 Dainippon Sumitomo Business Overview and Its Total Revenue
    • 10.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
    • 10.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020)
    • 10.12.5 Dainippon Sumitomo Recent Development
  • 13.13 Biocodex
    • 10.13.1 Biocodex Company Details
    • 10.13.2 Biocodex Business Overview and Its Total Revenue
    • 10.13.3 Biocodex Insomnia Therapy Introduction
    • 10.13.4 Biocodex Revenue in Insomnia Therapy Business (2015-2020)
    • 10.13.5 Biocodex Recent Development
  • 13.14 Eli Lilly and Company
    • 10.14.1 Eli Lilly and Company Company Details
    • 10.14.2 Eli Lilly and Company Business Overview and Its Total Revenue
    • 10.14.3 Eli Lilly and Company Insomnia Therapy Introduction
    • 10.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020)
    • 10.14.5 Eli Lilly and Company Recent Development
  • 13.15 Ebb Therapeutics
    • 10.15.1 Ebb Therapeutics Company Details
    • 10.15.2 Ebb Therapeutics Business Overview and Its Total Revenue
    • 10.15.3 Ebb Therapeutics Insomnia Therapy Introduction
    • 10.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
    • 10.15.5 Ebb Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Insomnia Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Merck & Co.
    Sanofi
    Pfizer
    Takeda Pharmaceutical Company Ltd.
    Purdue Pharmaceuticals L.P.
    Eisai, Co. Ltd.
    Meda Consumer Healthcare
    Pernix Therapeutics
    Vanda Pharmaceuticals
    ECR Pharmaceuticals
    Fidia Farmaceutici
    Dainippon Sumitomo
    Biocodex
    Eli Lilly and Company
    Ebb Therapeutics

    Market segment by Type, the product can be split into
    Non-pharmacological Therapy
    Pharmacological Therapy
    Market segment by Application, split into
    Hospital
    Ambulatory Surgical Center
    Home Care

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Insomnia Therapy status, future forecast, growth opportunity, key market and key players.
    To present the Insomnia Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Insomnia Therapy are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now